Daniella Beckman
Equibles does not estimate personal net worth.
About Daniella Beckman
Daniella Beckman was last confirmed as CFO at Tango Therapeutics, Inc. (TNGX) in a filing dated April 21, 2025. The proxy statement of Tango Therapeutics, Inc. reports total compensation of $1,155,775 for Daniella Beckman in fiscal 2025, including a base salary of $502,877. Disclosed compensation is on record for 6 fiscal years.
Affiliation history
-
Start not stated–2025-04-21
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tango Therapeutics, Inc. (TNGX) | Former Chief Financial Officer | $502,877 | $1,155,775 |
| 2024 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | $486,314 | $3,166,290 |
| 2023 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | $441,777 | $1,522,744 |
| 2022 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | $425,100 | $1,516,879 |
| 2021 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | $377,945 | $3,176,664 |
| 2020 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | $323,447 | $834,374 |
Recent activity
No call appearances or filed executive changes recorded yet.